Intensive five day intravenous insulin treatment combined with enteral feeding in hyperglycemic ischemic stroke patients: a feasibility study

Intensive five day intravenous insulin treatment combined with enteral feeding in hyperglycemic ischemic stroke patients: a feasibility study - Intensive insulin therapy post stroke

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON30354

Enrollment

Registered

2006-11-10

Start date

2006-10-15

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

1) Intraveneus insulin 2) Glucose control with standarized finger-prick procedure. 3) Enteral tube feeding

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Supratentorial ischemic stroke last 24hrs glucose > 7.0 mmol/l

Exclusion criteria

Exclusion criteria: cerebral hemorrhage history with diabetes mellitus dercrease consciousness

Design outcomes

Primary

Measure	Time frame
Glucose profiles: area under the curve (AUC) > 6.1 mmol/l and AUC	—

Secondary

Measure	Time frame
1) Time needed to perform all actions necessary for intensive insulin treatment. 2) Adverse reactions a) Hypoglycemic episodes b) Incidence of aspiration pneumonia c) Infection or skin irritation at the site of tube insertion	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)